HGH reported FY 2025 revenue of SGD 54.6 million and profit for the year of SGD 5.2 million, with profit attributable to shareholders of SGD 5.2 million and basic EPS of 0.29 Singapore cents. For 2H 2025, revenue was SGD 30.5 million and profit for the period was SGD 3.5 million (profit attributable to shareholders: SGD 3.5 million; basic EPS: 0.20 Singapore cents). FY 2025 gross profit was SGD 14.0 million, while finance costs were SGD 0.4 million. As at 31 Dec 2025, HGH had cash and bank balances of SGD 6.5 million, total assets of SGD 90.8 million and net assets of SGD 51.1 million; net asset value per share was 2.88 Singapore cents. The group also reported investment properties with a carrying amount of SGD 41.2 million, with a valuation of SGD 60.0 million as at 8 Dec 2025 by an independent valuer. Management said FY 2025 revenue increased by SGD 33.33 million compared with FY 2024, driven mainly by higher revenue from its ready-mix concrete segment (Premium Concrete) following the commencement of a newly completed ready-mix plant and higher production capacity, alongside higher activity in underground cable installation and road reinstatement (Poh Huat Heng). HGH did not recommend a dividend for FY 2025, citing the intention to preserve financial resources for future projects in 2026. Subsequent to year-end, it completed a RMB 20.0 million subscription for a 13.5% stake in Cool Farms Holding Pte. Ltd. on 8 Jan 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HGH Holdings Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: Y15X54LMHF65NO92) on February 26, 2026, and is solely responsible for the information contained therein.